Fikret Büyükkaya

Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04

Serkan Kuyumcu, Bilal Kovan, Fikret Büyükkaya et al. · Clinical Nuclear Medicine · 2021 · 87 citations

Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT

Serkan Kuyumcu, Duygu Has-Şimsek, Fikret Büyükkaya et al. · Clinical Nuclear Medicine · 2019 · 52 citations

Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer

Serkan Kuyumcu, Fikret Büyükkaya, Ayça İribaş et al. · Annals of Nuclear Medicine · 2017 · 48 citations

Urology, Genitourinary Cancer, Medicine +6

Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results

Serkan Kuyumcu, Emine Göknur Işık, Tarık Onur Tiryaki et al. · Annals of Nuclear Medicine · 2021 · 34 citations

Hematological Malignancy, 68Ga-pentixafor Pet/ct, Medicine +6

225Ac-Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer

Serkan Kuyumcu, Duygu Has Şimşek, Fikret Büyükkaya et al. · Clinical Nuclear Medicine · 2021 · 24 citations